Mitogenic stimulation accelerates influenza-induced mortality by increasing susceptibility of alveolar type II cells to infection

Abstract

Development of pneumonia is the most lethal consequence of influenza, increasing mortality more than 50-fold compared with uncomplicated infection. The spread of viral infection from conducting airways to the alveolar epithelium is therefore a pivotal event in influenza pathogenesis. We found that mitogenic stimulation with keratinocyte growth factor (KGF) markedly accelerated mortality after infectious challenge with influenza A virus (IAV). Coadministration of KGF with IAV markedly accelerated the spread of viral infection from the airways to alveoli compared with challenge with IAV alone, based on spatial and temporal analyses of viral nucleoprotein staining of lung tissue sections and dissociated lung cells. To better define the temporal relationship between KGF administration and susceptibility to IAV infection in vivo, we administered KGF 120, 48, 24, and 0 h before intrapulmonary IAV challenge and assessed the percentages of proliferating and IAV-infected, alveolar type II (AECII) cells in dispersed lung cell populations. Peak AECII infectivity coincided with the timing of KGF administration that also induced peak AECII proliferation. AECII from mice that were given intrapulmonary KGF before isolation and then infected with IAV ex vivo exhibited the same temporal pattern of proliferation and infectious susceptibility. KGF-induced increases in mortality, AECII proliferation, and enhanced IAV susceptibility were all reversed by pretreatment of the animals with the mTOR inhibitor rapamycin before mitogenic stimulation. Taken together, these data suggest mTOR signalingdependent, mitogenic conditioning of AECII is a determinant of host susceptibility to infection with IAV. viral pneumonia | influenza A | alveolar epithelial type II | mitogen | mTOR

Identification and characterization of GLDC as host susceptibility gene to severe influenza

“…At the first glance, the susceptibility to H7N9 infection and the susceptibility to severe H1N1 infection are not equivalent issues. In fact, H7N9 infection and severe H1N1 infection essentially shared the same pathology, i.e., viral pneumonia, the most lethal consequence of influenza (Nikolaidis et al , ). Overall, pandemic H1N1 viruses exhibit binding specificity to human‐type α2,6‐linked sialic acid receptor (Zhou et al , ); the viruses tend to replicate more actively in human bronchus than in lung tissue (Chan et al , ).…”

Pathogenesis of COVID-19 from a cell biology perspective

“…Recovery will require a vigorous innate and acquired immune response and epithelial regeneration. From my perspective, similar to influenza, administrating epithelial growth factors such as KGF might be detrimental and might increase the viral load by producing more ACE2 expressing cells [19]. Elderly individuals are particularly at risk because of their diminished immune response and reduced ability to repair the damaged epithelium.…”

Inhaled biguanides and mTOR inhibition for influenza and coronavirus (Review)

“…In animal studies, rapamycin was shown to promote cross-strain protection against lethal infection with influenza virus of various subtypes when administered during immunization with influenza virus subtype H3N2 (7). Mitogenic stimulation accelerates influenza-induced mortality in animals by increasing susceptibility of alveolar type II cells to infection, and pre-treatment with rapamycin reverses this effect (8).…”